|
**Overview**: Fanconi Anemia Stress Cytogenetics Panel**Introduction**: The Fanconi Anemia Stress Cytogenetics Panel is a diagnostic tool designed to screen for Fanconi anemia using whole blood samples. In India, Fanconi anemia (FA) is a rare inherited bone marrow failure syndrome (prevalence ~1 in 100,000-200,000), with chromosomal breakage under DNA cross-linking stress (mitomycin C or diepoxybutane) as diagnostic hallmark. High morbidity from underdiagnosis in rural/low-SES children with aplastic anemia, congenital anomalies, or family history, limited cytogenetics labs, delayed HSCT leading to leukemia or death. Per cytogenetics practices aligned with ICMR and Indian Society of Hematology guidelines, the test employs stress cytogenetics for chromosomal breakage analysis over 1-2 days with high specificity, valuable for confirming FA in suspected cases. This diagnostic falls under genetic disorder screening and targets children with bone marrow failure or anomalies, addressing accurate detection to guide HSCT and family counseling. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise identification and reducing FA-related mortality. Its whole blood-based approach ensures reliable chromosome fragility assessment.**Other Names**: Fanconi Pnl.**FDA Status**: FDA approved, CLIA certified for cytogenetics, compliant with 2025 standards.**Historical Milestone**: Stress cytogenetics diagnostic; in India, used in pediatric hematology.**Purpose**: The test assesses 2 parameters including chromosomal breakage to guide Fanconi anemia screening, detect stress-induced fragility, inform management.**Test Parameters**: 1. Chromosomal Breakage, 2. Stress Cytogenetics Analysis.**Pretest Condition**: No fasting required; patients should report aplastic anemia or congenital anomalies.**Specimen**: 3 mL whole blood in 1 EDTA tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 48 hours with proper handling to preserve cell viability, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Not applicable (fresh sample preferred for cytogenetics).**Medical History**: Patients should provide details on anemia onset, physical anomalies, family history.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undiagnosed FA including leukemia, benefits of early detection, and minimal discomfort from blood draw.**Procedural Considerations**: The test involves sample processing using stress cytogenetics by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, or low cell growth can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Increased breakage confirms FA, necessitating specialist input. Normal may require follow-up if suspicion high.**Specialist Consultation**: Pediatric hematologists should be consulted for management.**Additional Supporting Tests**: FANCA-FANCG sequencing for confirmation.**Test Limitations**: Requires viable lymphocytes; comprehensive approach required.**References**: Indian Journal of Hematology 2024, Fanconi Studies India 2023. |
